|
Volumn 18, Issue 6, 2002, Pages 591-603
|
The 2001 Canadian Hypertension Recommendations - What is new and what is old but still important;Les recommandations canadiennes de 2001 sur l'hypertension: Quoi de neuf et quels éléments antérieurs demeurent importants?
a a,a a,a a,a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
HYDRALAZINE;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
LONG ACTING DRUG;
LOOP DIURETIC AGENT;
MINOXIDIL;
PERINDOPRIL;
POTASSIUM SPARING DIURETIC AGENT;
SPIRONOLACTONE;
THIAZIDE DIURETIC AGENT;
UNCLASSIFIED DRUG;
VERAPAMIL;
ANTIHYPERTENSIVE ACTIVITY;
BLOOD PRESSURE REGULATION;
CANADA;
CARDIOVASCULAR RISK;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG CONTRAINDICATION;
DRUG INDICATION;
DRUG POTENTIATION;
HUMAN;
HYPERALDOSTERONISM;
HYPERTENSION;
HYPOKALEMIA;
LABORATORY TEST;
LIFESTYLE;
MEDICAL LITERATURE;
PRACTICE GUIDELINE;
RENOVASCULAR HYPERTENSION;
REVIEW;
RISK ASSESSMENT;
|
EID: 0036054575
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: 10.1002/bjs5.50138 Document Type: Review |
Times cited : (12)
|
References (16)
|